Canadian Blood Services is in talks with companies that pay donors for plasma as it faces a decrease in collections.
saying it is in “ongoing discussion with governments and the commercial plasma industry” on how to more than double domestic plasma collection to 50 per cent of supply.
It issued a plea earlier this week for donors to book and keep appointments, noting collections have been falling since July 1 despite a constant need for plasma in transfusions for surgery, cancer patients and accident victims.Article contenttap here to see other videos from our teamThe number of people who donate blood regularly dropped by 31,000 during the COVID-19 pandemic, leaving the organization with its smallest donor base in a decade, it said.
Provinces have jurisdiction over whether paid donations are allowed. But any plasma protein product — chiefly immunoglobulins, which contain antibodies against diseases — must also get the green light from Health Canada before hitting hospitals. The O- type is the one most commonly used in transfusions for traumas and emergency surgeries, since anyone can receive its red blood cells. The O+ blood type is also in high demand due to its compatibility with any other positive red blood cell.Article content
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Can You Eat Ice Cream if You Have High Blood Sugar?Ice cream is delicious but can be loaded with sugar. So, can you still eat ice cream even if you have high blood sugar levels?
Read more »
If blood is red, why do veins look bluish?It's commonly said that oxygen-rich blood is red, while oxygen-poor blood is blue. But is that really true?
Read more »
Covid: Evusheld antibody protection ruled out for most vulnerableThe antibody injection had promised a protection boost to those with conditions such as blood cancer.
Read more »
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial - Nature MedicineIn a phase 2 trial, monitoring tumor resistance mutations in blood using liquid biopsies allowed to rationally guide subsequent therapy with anti-EGFR antibodies in patients with ColorectalCancer. EGFR biomarkers Cancer Albert0Bardelli BardelliLab
Read more »
‘There was blood everywhere:’ Witness to San Antonio woman’s hacking death told to clean it up or be killedVanessa Marie Vargas said she had just finished cooking food for everyone when she walked...
Read more »
'I went for a contraceptive check up, but doctors made a shocking discovery''I was dumbfounded. Aside from high blood pressure, I had no symptoms at all — nothing.' Read more:
Read more »